Literature DB >> 18311899

Opioids and efflux transporters. Part 2: P-glycoprotein substrate activity of 3- and 6-substituted morphine analogs.

Christopher W Cunningham1, Susan L Mercer, Hazem E Hassan, John R Traynor, Natalie D Eddington, Andrew Coop.   

Abstract

Continuing our studies investigating opioids with reduced P-glycoprotein (P-gp) substrate activity, a series of known 3- and 6-hydroxy, -methoxy, and -desoxymorphine analogs was synthesized and analyzed for P-gp substrate activity and opioid binding affinity. 6-Desoxymorphine ( 7) showed high affinity for opioid receptors and did not induce P-gp-mediated ATP hydrolysis. Additionally, 7 demonstrated morphine-like antinociceptive potency in mice, indicating this compound as an ideal lead to further evaluate the role of P-gp in opioid analgesic tolerance development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18311899      PMCID: PMC3401598          DOI: 10.1021/jm701457j

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  23 in total

Review 1.  Opioid tolerance-in search of the holy grail.

Authors:  Brigitte L Kieffer; Christopher J Evans
Journal:  Cell       Date:  2002-03-08       Impact factor: 41.582

2.  Deoxymorphines: role of the phenolic hydroxyl in antinociception and opiate receptor interactions.

Authors:  J Reden; M F Reich; K C Rice; A E Jacobson; A Brossi; R A Streaty; W A Klee
Journal:  J Med Chem       Date:  1979-03       Impact factor: 7.446

3.  A rapid, high-yield conversion of codeine to morphine.

Authors:  K C Rice
Journal:  J Med Chem       Date:  1977-01       Impact factor: 7.446

4.  Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs.

Authors:  M King; W Su; A Chang; A Zuckerman; G W Pasternak
Journal:  Nat Neurosci       Date:  2001-03       Impact factor: 24.884

5.  Effect of P-glycoprotein modulation on the clinical pharmacokinetics and adverse effects of morphine.

Authors:  J Drewe; H A Ball; C Beglinger; B Peng; A Kemmler; H Schächinger; W E Haefeli
Journal:  Br J Clin Pharmacol       Date:  2000-09       Impact factor: 4.335

Review 6.  A primer on the mechanics of P-glycoprotein the multidrug transporter.

Authors:  M Hennessy; J P Spiers
Journal:  Pharmacol Res       Date:  2006-10-20       Impact factor: 7.658

7.  Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization.

Authors:  Li He; Jamie Fong; Mark von Zastrow; Jennifer L Whistler
Journal:  Cell       Date:  2002-01-25       Impact factor: 41.582

8.  Rational use of in vitro P-glycoprotein assays in drug discovery.

Authors:  J W Polli; S A Wring; J E Humphreys; L Huang; J B Morgan; L O Webster; C S Serabjit-Singh
Journal:  J Pharmacol Exp Ther       Date:  2001-11       Impact factor: 4.030

Review 9.  P-glycoprotein: from genomics to mechanism.

Authors:  Suresh V Ambudkar; Chava Kimchi-Sarfaty; Zuben E Sauna; Michael M Gottesman
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

10.  Variable modulation of opioid brain uptake by P-glycoprotein in mice.

Authors:  Claude Dagenais; Candace L Graff; Gary M Pollack
Journal:  Biochem Pharmacol       Date:  2004-01-15       Impact factor: 5.858

View more
  9 in total

1.  Regulation of gene expression in brain tissues of rats repeatedly treated by the highly abused opioid agonist, oxycodone: microarray profiling and gene mapping analysis.

Authors:  Hazem E Hassan; Alan L Myers; Insong J Lee; Hegang Chen; Andrew Coop; Natalie D Eddington
Journal:  Drug Metab Dispos       Date:  2010-01       Impact factor: 3.922

Review 2.  Cholinergic modulation by opioid receptor ligands: potential application to Alzheimer's disease.

Authors:  William C Motel; Andrew Coop; Christopher W Cunningham
Journal:  Mini Rev Med Chem       Date:  2013-03       Impact factor: 3.862

Review 3.  Opioid analgesics and P-glycoprotein efflux transporters: a potential systems-level contribution to analgesic tolerance.

Authors:  Susan L Mercer; Andrew Coop
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

Review 4.  Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A.

Authors:  Christopher W Cunningham; Richard B Rothman; Thomas E Prisinzano
Journal:  Pharmacol Rev       Date:  2011-03-28       Impact factor: 25.468

5.  A One-Step Synthesis of β-Bromocodide from Codeine.

Authors:  Christopher W Cunningham; Jeffrey R Deschamps; Andrew Coop
Journal:  J Pharm Sci Pharmacol       Date:  2014-03

6.  Opioids and efflux transporters. Part 3: P-glycoprotein substrate activity of 3-hydroxyl addition to meperidine analogs.

Authors:  Susan L Mercer; Christopher W Cunningham; Natalie D Eddington; Andrew Coop
Journal:  Bioorg Med Chem Lett       Date:  2008-04-25       Impact factor: 2.823

7.  Opioids and efflux transporters. Part 4: influence of N-substitution on P-glycoprotein substrate activity of noroxymorphone analogues.

Authors:  Matthew D Metcalf; Andrew D Rosicky; Hazem E Hassan; Natalie D Eddington; Andrew Coop; Christopher W Cunningham; Susan L Mercer
Journal:  Bioorg Med Chem Lett       Date:  2014-05-22       Impact factor: 2.823

Review 8.  Modulation of Opioid Transport at the Blood-Brain Barrier by Altered ATP-Binding Cassette (ABC) Transporter Expression and Activity.

Authors:  Junzhi Yang; Bianca G Reilly; Thomas P Davis; Patrick T Ronaldson
Journal:  Pharmaceutics       Date:  2018-10-18       Impact factor: 6.321

Review 9.  Peripheral Opioid Receptor Antagonists for Opioid-Induced Constipation: A Primer on Pharmacokinetic Variabilities with a Focus on Drug Interactions.

Authors:  Jeffrey Gudin; Jeffrey Fudin
Journal:  J Pain Res       Date:  2020-02-25       Impact factor: 3.133

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.